{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:13:13Z","timestamp":1777929193317,"version":"3.51.4"},"reference-count":49,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that often manifests during productive years and frequently involves the central nervous system (CNS), including cognitive dysfunction, which occurs at twice the prevalence of the general population. While the Montreal Cognitive Assessment (MoCA) is effective for detecting mild cognitive impairment, no reliable biomarkers that indicate SLE patients at risk of cognitive dysfunction exist. Neuron-specific enolase (NSE), a specific marker of neuronal cell damage, has been shown in several studies to be highly expressed in cognitive dysfunction. This study serves as a preliminary investigation to examine the relationship between serum NSE levels and cognitive function in SLE patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross-sectional study was conducted from January to August 2024 at Hasan Sadikin General Hospital, including SLE patients aged 18\u201355 years meeting the EULAR\/ACR 2019 criteria. Exclusion criteria included pregnancy, neurological disorders (e.g., CNS infections, neurodegenerative diseases, stroke, epilepsy, head trauma), psychiatric conditions, substance abuse, systemic metabolic disorders, malignancy, other autoimmune diseases, or HIV. Cognitive function was assessed using MoCA-Indonesian version (MoCA-Ina) and serum NSE levels were measured. Associations between serum NSE and MoCA-Ina scores were analyzed using Spearman\u2019s correlation (\n                      <jats:italic>p<\/jats:italic>\n                      &lt; .05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eighty-one participants (median age 32 years; 93.8% female) were included. Cognitive dysfunction (MoCA-Ina &lt;26) was identified in 38.3%. Median serum NSE levels were higher in participants with cognitive dysfunction compared to those with normal cognition (14.0\u00a0ng\/mL vs 12.7\u00a0ng\/mL). Serum NSE levels showed a negative correlation with MoCA-Ina total scores (r = \u22120.225,\n                      <jats:italic>p<\/jats:italic>\n                      = .022) and executive function (r = \u22120.204,\n                      <jats:italic>p<\/jats:italic>\n                      = .034). Cognitive dysfunction was also associated with longer disease duration and a history of seizures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates a significant association between neuronal injury, as indicated by elevated serum neuron-specific enolase (NSE) levels, and cognitive impairment in SLE patients, with a particular impact on executive function. Longitudinal studies incorporating neuronal biomarkers are essential to provide deeper insights into the progression of cognitive dysfunction in SLE patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09612033251366396","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T15:13:07Z","timestamp":1754752387000},"page":"1119-1127","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Cognitive dysfunction in systemic lupus erythematosus: A pilot study on the role of serum neuron-specific enolase levels"],"prefix":"10.1177","volume":"34","author":[{"given":"Aulia Putri","family":"Ayu","sequence":"first","affiliation":[{"name":"Department of Neurology, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1310-674X","authenticated-orcid":false,"given":"Laniyati","family":"Hamijoyo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suryani","family":"Gunadharma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofiati","family":"Dian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sobaryati","family":"Mansur","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aih","family":"Cahyani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0787-2907","authenticated-orcid":false,"given":"Paulus Anam","family":"Ong","sequence":"additional","affiliation":[{"name":"Department of Neurology, Dr Hasan Sadikin Hospital, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05183-4"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617722000418"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00312-0"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.998328"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.00024"},{"key":"e_1_3_4_7_2","first-page":"995","article-title":"Meta-analysis of neuron specific enolase in predicting pediatric brain injury outcomes","volume":"16","author":"Nakhjavan Shahraki B","year":"2017","unstructured":"Nakhjavan Shahraki B, Yousefifard M, Oraii A, et al. Meta-analysis of neuron specific enolase in predicting pediatric brain injury outcomes. EXCLI Journal 2017; 16: 995\u20131008.","journal-title":"EXCLI Journal"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8020033"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.788150"},{"key":"e_1_3_4_10_2","volume-title":"Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects","author":"Isgr\u00f2 MA","year":"2015","unstructured":"Isgr\u00f2 MA, Bottoni P, Scatena R. In: S R (ed). Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Dordrecht: Springer, 2015."},{"issue":"2","key":"e_1_3_4_11_2","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman DD","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288\u2013291.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012787"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2017.202"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000876"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.inat.2022.101633"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-023-00300-8"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/2059902118792434"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315624022"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161125"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13010104"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000835"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.37275\/ijr.v11i1.142"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2829018"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.06.017"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2021.02.021"},{"issue":"6","key":"e_1_3_4_26_2","first-page":"229","article-title":"Exploring the neuroinflammatory pathway in epilepsy and cognitive impairment: role of HMGB1 and translational challenges","volume":"29","author":"Ngadimon IW","year":"2024","unstructured":"Ngadimon IW, Seth EA, Shaikh MF. Exploring the neuroinflammatory pathway in epilepsy and cognitive impairment: role of HMGB1 and translational challenges. FBL 2024; 29(6): 229.","journal-title":"FBL"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320908947"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.30.1.7"},{"issue":"9","key":"e_1_3_4_29_2","first-page":"e17969","article-title":"Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges","volume":"13","author":"Sarwar S","year":"2021","unstructured":"Sarwar S, Mohamed AS, Rogers S, et al. Neuropsychiatric systemic lupus erythematosus: a 2021 update on diagnosis, management, and current challenges. Cureus 2021; 13(9): e17969.","journal-title":"Cureus"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_1475_20"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29040747"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.1184"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2019.1564040"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320958061"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035557"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S249126"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160510281"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001214"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315593818"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-812344-7.00016-9"},{"issue":"2","key":"e_1_3_4_41_2","first-page":"1968","article-title":"Changes of serum neuron specific enolase and S100-\u03b2 protein and their correlations with cognitive impairment in patients with moderate traumatic brain injury","volume":"20","author":"Zhang Y","year":"2017","unstructured":"Zhang Y, Ma J, Meng Y. Changes of serum neuron specific enolase and S100-\u03b2 protein and their correlations with cognitive impairment in patients with moderate traumatic brain injury. Chin J Traumatol (Engl Ed) 2017; 20(2): 1968\u20131972.","journal-title":"Chin J Traumatol (Engl Ed)"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1494"},{"issue":"1","key":"e_1_3_4_43_2","first-page":"1","article-title":"Serum level of neuron-specific enolase in patients with past ischemic stroke","volume":"22","author":"Hrytsiuk TD","year":"2016","unstructured":"Hrytsiuk TD. Serum level of neuron-specific enolase in patients with past ischemic stroke. Archive of Clinical Medicine 2016; 22(1): 1\u20137.","journal-title":"Archive of Clinical Medicine"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317751859"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001151"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001221"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000612"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316668417"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.38009"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316643170"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251366396","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09612033251366396","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09612033251366396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:29:12Z","timestamp":1777678152000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09612033251366396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1177\/09612033251366396"],"URL":"https:\/\/doi.org\/10.1177\/09612033251366396","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]}}}